Your search for esrd returned 11 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Mpr-drug-news remove
Brian Park, PharmD remove
Post remove

Your search for esrd returned 11 results

Sort Results:

Relevant Recent

Invokana Approved to Slow Progression of Diabetic Nephropathy in T2D Patients

The FDA has approved a new indication for Invokana (canagliflozin; Janssen) to reduce the risk of end-stage renal disease, doubling of serum creatinine, cardiovascular (CV) death, and hospitalization for heart failure (HF) in adults with type 2 diabetes (T2D) and diabetic nephropathy with albuminuria >300mg/day.